Dako: Dako, an Agilent Technologies Company, Announces Expanded Use of PD-L1 Diagnostic Test in Europe

CARPINTERIA, Calif.-(BUSINESS WIRE)-Dako, Agilent Pathology Solutions, a worldwide leader in partnering with pharmaceutical companies to develop immunohistochemical-based diagnostics for cancer therapy, today announced an expansion of the intended use of the PD-L1 IHC 28-8 pharmDx...